Protein Binding Assays Industry

The global protein binding assays market is projected to attain a value of USD 896.3 million by the year 2030, expanding at a robust compound annual growth rate (CAGR) of 10.2% during the forecast period from 2024 to 2030, as per a new report released by Grand View Research, Inc. The adoption of protein binding assays is steadily increasing, especially in the preclinical phases of drug discovery and development programs. These assays play a crucial role in identifying target molecules and offer vital insights into the physicochemical and biological properties of therapeutic drugs and biologics under investigation.

One of the key factors propelling market growth is the rising trend of pharmaceutical companies outsourcing their research and development (R&D) activities. As these companies focus on developing innovative therapeutics, they are increasingly relying on third-party service providers for advanced assays, including protein binding evaluations. The growing availability of specialized firms that offer these analytical and investigative services for drug molecules is expected to support and enhance market expansion over the forecast period.

Protein binding assays are essential tools in evaluating the Absorption, Distribution, Metabolism, and Excretion (ADME) characteristics of therapeutic candidates during the drug development process. These assays enable researchers to predict how a drug interacts with proteins in the body, which directly impacts the drug's bioavailability and therapeutic efficacy. Moreover, estimating the safety margins of new drug candidates is a vital step in preclinical evaluation. This can be achieved by quantifying the degree to which a novel chemical entity binds to plasma proteins, helping researchers make informed decisions about dosage levels and potential risks.

Curious about the Protein Binding Assays Market, Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Protein Binding Assays Market Segments Highlights:

  • The services segment dominated with a market share of 44.7% in 2023. Technological advancements, strategic investments, and increasing consumer demand constitute market growth.
  • The equilibrium dialysis dominated with a share of 49.7% in 2023. Scientists and researchers prefer this technique due to its low price and high accuracy. 
  • The pharmaceuticals and biotechnology segment dominated with a 46.4% market share in 2023. Factors such as a wide and strong distribution network and significant investments in drug discovery boost the segment growth.
  • The North America protein binding assays dominated the global market with a share of 40.8% in 2023.

Protein Binding Assays Market Report Segmentation

Grand View Research has segmented the global protein binding assays market on the basis of technology, products & services, end use, and region:

Protein Binding Assays Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments
  • Kits & Reagents
  • Services

Protein Binding Assays Products & Services Outlook (Revenue, USD Million, 2018 - 2030)

  • Ultracentrifugation
  • Equilibrium Dialysis
  • Ultrafiltration
  • Surface Plasmon Resonance
  • Others

Protein Binding Assays End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Others

Protein Binding Assays Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • Kuwait
    • South Africa

Key Protein Binding Assays Company Insights

  • Thermo Fisher Scientific
  • ADMEcell, Inc.
  • Beckman Coulter, Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • Abzena Ltd
  • Abcam Limited
  • GVK Biosciences Private Limited
  • Promega Corporation
  • Arryait Corporation
  • Charles River Laboratories
  • Sovicell
  • Eurofins Scientific
  • 3B Pharmaceuticals
  • Creative Biolabs
  • Evotec SE
  • BioDuro-Sundia
  • Merck KDaA

Order a free sample PDF of the Protein Binding Assays Market Intelligence Study, published by Grand View Research.